Mental Health and Suicidal Behaviors
Publicaciones destacadas
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Rose AMC, Pozo F, Martínez-Baz I, Mazagatos C, Bossuyt N, Cauchi JP, et al. Influenza Other Respir Viruses. 2024 Feb;18(2):e13255.
PUBMED DOIThe Hospital Survey Study Group C. A low-cost, sustainable, second generation system for surveillance of people living with HIV in Spain: 10-year trends in behavioural and clinical indicators, 2002 to 2011
Diez M, Diaz A, Garriga C, Pons M, Ten A, Marcos H, Gutierrez G, Moreno S, Gonzalez-Garcia J, Barrios A, Arponen S, Garcia M, Royo M, Toledo J, Gonzalez G, Aranguren R, Izquierdo A, Viloria LJ, Elizalde L, Martinez E, Castrillejo D, Lopez I, Redondo C, Cano A, The Hospital Survey Study Group C. A low-cost, sustainable, second generation system for surveillance of people living with HIV in Spain: 10-year trends in behavioural and clinical indicators, 2002 to 2011. Euro Surveill. 2014; 19(20). pii: 20805
PUBMED DOIOmics feature selection with the extended SIS R package: identification of a body mass index epigenetic multimarker in the Strong Heart Study
Domingo-Relloso A, Feng Y, Rodriguez-Hernandez Z, Haack K, Cole SA, Navas-Acien A, Tellez-Plaza M, Bermudez JD. Omics feature selection with the extended SIS R package: identification of a body mass index epigenetic multimarker in the Strong Heart Study. Am J Epidemiol. 2024 Jul 8;193(7):1010-1018.
PUBMED DOIThe effectiveness of lifestyle interventions on type 2 diabetes and gestational diabetes incidence and cardiometabolic outcomes: A systematic review and meta-analysis of evidence from low- and middle-income countries.
Sagastume D, Siero I, Mertens E, Cottam J, Colizzi C, Peñalvo JL. The effectiveness of lifestyle interventions on type 2 diabetes and gestational diabetes incidence and cardiometabolic outcomes: A systematic review and meta-analysis of evidence from low- and middle-income countries. EClinicalMedicine. 2022 Sep 9;53:101650.
PUBMED DOIIdentification of methodological issues regarding direct impact indicators of COVID-19: a rapid scoping review on morbidity, severity and mortality.
Garriga C, Valero-Gaspar T, Rodriguez-Blazquez C, Diaz A, Bezzegh P, Daňková Š, Unim B, Palmieri L, Thiβen M, Pentz R, Cilović-Lagarija Š, Jogunčić A, Feteira-Santos R, Vuković J, Idavain J, Curta A, Sandu P, Vinko M, Forjaz MJ. Identification of methodological issues regarding direct impact indicators of COVID-19: a rapid scoping review on morbidity, severity and mortality. Eur J Public Health. 2024 Jul 1;34(Supplement_1):i3-i10.
PUBMED DOIUtility of MF-non coding region for measles molecular surveillance during post-elimination phase, Spain, 2017-2020.
Jacqueline C, Gavilán AM, López-Perea N, Penedos AR, Masa-Calles J, Echevarría JE, Fernández-García A; MMR Study Group. Front Microbiol. 2023 May 22;14:1143933.
DOIHepatitis of unknown aetiology in children – epidemiological overview of cases reported in Europe, 1 January to 16 June 2022
9. Vidal A.R., Vaughan A., Innocenti F., Colombe S., Nerlander L., Rachwal N., Ciancio B.C., Mougkou A., Carvalho C., Delgado E., Mook P., De Muylder G., Peeters M., Tenev T., Golkocheva-Markova E., Jensen V.V.S., Koch A., Figoni J., Brouard C., Nikolopoulou G., Zisouli A., Murphy N., Broderick A., Goldberg L., Rich R., Sagie L.H., Tosti M.E., Suligoi B., Joosten R., Pijnacker R., Fjeldheim I., Heen E., Stȩpień M., Polański P., Marinho R.T., Martins J.V., Varela C., Avellón A., Andersson E., Mörk M.J., Mandal S., Watson C., Coughlan L., Chand M., Neill C., Bradley D.T., Li K., O'Leary M., McInnes N., Williams C.J., Moore C., Gjini A., Duffell E., Pebody R.. Hepatitis of unknown aetiology in children – epidemiological overview of cases reported in Europe, 1 January to 16 June 2022. Euro Surveill. 2022;27(31):pii=2200483.
PUBMED DOILong-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
Suárez-García I, Alejos B, Moreno C, Martín Torres J, Masiá M, García-Fraile LJ, Riera M, Dalmau D, Rodríguez-Rosado R, Muga R, Moreno S, Jarrín I; CoRIS cohort. J Antimicrob Chemother. 2025 Mar 3;80(3):682-691.
PUBMED DOI